VolitionRX
VNRX
VNRX
25 hedge funds and large institutions have $12M invested in VolitionRX in 2025 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
Holders
25
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.56M | |
| 2 | +$41.4K | |
| 3 | +$36.2K | |
| 4 |
Bank of New York Mellon
New York
|
+$18.2K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$10.8K |
Top Sellers
| 1 | -$164K | |
| 2 | -$40.9K | |
| 3 | -$29.7K | |
| 4 |
TSS
Two Sigma Securities
New York
|
-$16.3K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$14.4K |